On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Classification of hepatic encephalopathy
- Hepatic encephalopathy in cirrhosis (1)
- Hepatic encephalopathy in cirrhosis (2)
- Transjugular intrahepatic portosystemic shunt
- Hepatic encephalopathy post-TIPS
- Survival in TIPS patients as a function of HE grade
- Neuropathology of HE in chronic liver failure
- Pathogenesis of HE in cirrhosis: neuroimaging (1)
- T1-weighted MRI due to manganese deposition
- Cirrhosis-related Parkinsonism: MRI findings
- Cirrhosis-related Parkinsonism
- Pathogenesis of HE in cirrhosis: neuroimaging (2)
- PET studies in cirrhosis (1)
- Deactivation of anterior cingulate cortex
- NCT-B test
- PET studies in cirrhosis (2)
- 13NH3 PET images of brain in a cirrhotic patient
- Neuroinflammation and HE in cirrhosis
- SIRS in cirrhosis
- Circulating TNF alpha in cirrhotic patients
- Serum TNF alpha in HE grade improvement
- Microglial activation in biliary cirrhosis model
- Translocator protein and HE in cirrhosis
- Translocator protein
- Translocator protein complex
- IBP - a key subunit of translocator protein
- Increased translocator protein sites in HE brain
- PET imaging using the translocator protein ligand
- Translocator protein activation
- Modulatory site for neurosteroids
- GABA-A receptor activation by neurosteroids
- Allopregnanolone levels and hepatic coma
- Prevention and treatment of HE in cirrhosis (1)
- Treatment of precipitating factors
- Nutrition
- Non-metabolizeable disaccharides
- Antibiotics
- L-ornithine L-aspartate lowers ammonia levels
- Summary
- Prevention and treatment of HE in cirrhosis (2)
- Flumazenil in HE: results of a meta-analysis
- Emerging new therapeutic approaches
- Take home messages (1)
- Take home messages (2)
- Acknowledgements
Topics Covered
- Classification of hepatic encephalopathy
- Hepatic encephalopathy in cirrhosis
- Transjugular intrahepatic portosystemic shunt (TIPS)
- Hepatic encephalopathy post-TIPS
- Neuropathology of hepatic encephalopathy in chronic liver failure
- Cirrhosis-related Parkinsonism
- PET studies in cirrhosis
- Neuroinflammation and hepatic encephalopathy in cirrhosis
- Systemic inflammatory response syndrome (SIRS) in cirrhosis
- Translocator protein and hepatic encephalopathy in cirrhosis
- Modulatory site for neurosteroids
- Prevention and treatment of hepatic encephalopathy in cirrhosis
- Emerging new therapeutic approaches
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Butterworth, R.F. (2013, November 5). Hepatic encephalopathy in cirrhosis: a disorder of glial-neuronal signalling [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/ITJG4890.Export Citation (RIS)
Publication History
- Published on November 5, 2013
Financial Disclosures
- Prof. Roger F. Butterworth, Speaker’s Bureau: Merz Pharmaceuticals, Frankfurt, Germany.
Hepatic encephalopathy in cirrhosis: a disorder of glial-neuronal signalling
Published on November 5, 2013
33 min
A selection of talks on Neuroscience
Hide